Surmodics | SRDX - Assets


Surmodics reported $169.82M in Assets for its fiscal quarter ending in June of 2025.





Assets Change Date
Abbott USD 86.71B 2.53B Dec/2025
Align Technology USD 6.23B 141K Dec/2025
Anika Therapeutics USD 190.27M 833K Dec/2025
Arrowhead Research USD 1.6B 218.89M Dec/2025
Artivion USD 884.8M 27.13M Dec/2025
Baxter International USD 20.06B 1.01B Dec/2025
Boston Scientific USD 43.67B 966M Dec/2025
EDAP TMS EUR 61.46M 6.88M Sep/2025
Edwards Lifesciences USD 13.27B 216.5M Sep/2025
Haemonetics USD 2.49B 48.73M Dec/2025
Heron Therapeutics USD 255.88M 6.93M Dec/2025
J&J USD 199.21B 6.39B Dec/2025
Merit Medical Systems USD 2.69B 54.92M Dec/2025
Mesa Laboratories USD 434.85M 4.5M Dec/2025
Nektar Therapeutics USD 280.41M 20.94M Dec/2025
Option Care Health USD 3.46B 24.08M Dec/2025
Stryker USD 47.84B 787M Dec/2025
Surmodics USD 169.82M 8.74M Jun/2025
Trinity Biotech USD 103.71M 4.08M Sep/2025